ACE and heart failure: Until recently, 3 classes of medications were the cornerstone of guideline-directed medical therapy for heart failure with reduced ejection fraction (HFrEF): angiotensin-converting enzyme inhibitors (ACE-Is) and angiotensin II receptor blockers (ARBs), β-blockers, and aldosterone receptor antagonists.